EmCyte Corporation

As the leader in Autologous Biologics, EmCyte Corporation delivers cutting-edge technology that supports evidence-based treatment methodology in the emerging field of regenerative medicine. Our product portfolio meets the highest achievable performance standards at the point of care and contains innovation that improves clinical outcomes for patients around the globe. Offering more power, versatility, efficiency, and quality at the point of care, EmCyte Corporation is committed to the continual development and improvement of devices used for autologous regenerative biologics and to the promotion of autologous therapies used to enhance the quality of life. Our devices are cleared for marketing through both...

Prp,medical manufacturing,pure prp,autologous platelet rich plasma,cell biologics,progenitor stem cell biologics,medical device,therapeutic biologics,and regenerative medicine

Emcyte corporation operates in the Medical device industry.

Emcyte corporation's revenue is 1m - 10m

Emcyte corporation has 11 - 50 employees.